(64) Methodologies to establish thresholds for carcinogenic and mutagenic substances may be developed taking into account the outcomes of RIPs.
(64) Ņemot vērā RIP rezultātus, var izstrādāt metodoloģijas, ar ko noteikt kancerogēnu un mutagēnu vielu robežlielumus.